The National Quality Forum Board of Directors has endorsed 19 measures related to pulmonary conditions and the critical care setting.
The measures focus on treatment processes and outcomes for asthma, chronic obstructive pulmonary disease and pneumonia. Three were new measures and 16 were maintenance measures. The measures are as follows:
Asthma
• 0036: Use of appropriate medications for people with asthma (NCQA)
• 0047: Asthma: Pharmacologic therapy for persistent asthma (AMA-PCPI)
• 1799: Medication management for people with asthma (MMA) (NCQA)
• 1800: Asthma medication ratio (AMR) (NCQA)
• 0548: Suboptimal asthma control (SAC) and absence of controller therapy (ACT) (Pharmacy Quality Alliance, Inc.)
• 0143: CAC-1: Relievers for inpatient asthma (Joint Commission) *reserve status
• 0144: CAC-2 Systemic corticosteroids for inpatient asthma (Joint Commission) *reserve status
COPD
• 0091: COPD: spirometry evaluation (AMA-PCPI)
• 0102: COPD: inhaled bronchodilator therapy (AMA-PCPI)
• 0577: Use of spirometry testing in the assessment and diagnosis of COPD (NCQA)
• 1825: COPD - management of poorly controlled COPD (ActiveHealth Management)
Pneumonia
• 0096: Empiric antibiotic for community-acquired bacterial pneumonia (AMA-PCPI)
• 0147: Initial antibiotic selection for community-acquired pneumonia (CAP) in immunocompetent patients (CMS)
• 0231: Pneumonia Mortality Rate (IQI #20) (AHRQ)
• 0468: Hospital 30-day, all-cause, risk-standardized mortality rate (RSMR) following pneumonia hospitalization (CMS)
Critical Care
• 0334: PICU Severity-adjusted length of stay (Virtual PICU Systems, LLC) *paired with 0335
• 0335: PICU Unplanned readmission rate (Virtual PICU Systems, LLC) *paired with 0334
• 0343: PICU Standardized Mortality Ratio (Virtual PICU Systems, LLC)
Imaging
• 0513: Thorax CT: Use of contrast material (CMS)
The measures focus on treatment processes and outcomes for asthma, chronic obstructive pulmonary disease and pneumonia. Three were new measures and 16 were maintenance measures. The measures are as follows:
Asthma
• 0036: Use of appropriate medications for people with asthma (NCQA)
• 0047: Asthma: Pharmacologic therapy for persistent asthma (AMA-PCPI)
• 1799: Medication management for people with asthma (MMA) (NCQA)
• 1800: Asthma medication ratio (AMR) (NCQA)
• 0548: Suboptimal asthma control (SAC) and absence of controller therapy (ACT) (Pharmacy Quality Alliance, Inc.)
• 0143: CAC-1: Relievers for inpatient asthma (Joint Commission) *reserve status
• 0144: CAC-2 Systemic corticosteroids for inpatient asthma (Joint Commission) *reserve status
COPD
• 0091: COPD: spirometry evaluation (AMA-PCPI)
• 0102: COPD: inhaled bronchodilator therapy (AMA-PCPI)
• 0577: Use of spirometry testing in the assessment and diagnosis of COPD (NCQA)
• 1825: COPD - management of poorly controlled COPD (ActiveHealth Management)
Pneumonia
• 0096: Empiric antibiotic for community-acquired bacterial pneumonia (AMA-PCPI)
• 0147: Initial antibiotic selection for community-acquired pneumonia (CAP) in immunocompetent patients (CMS)
• 0231: Pneumonia Mortality Rate (IQI #20) (AHRQ)
• 0468: Hospital 30-day, all-cause, risk-standardized mortality rate (RSMR) following pneumonia hospitalization (CMS)
Critical Care
• 0334: PICU Severity-adjusted length of stay (Virtual PICU Systems, LLC) *paired with 0335
• 0335: PICU Unplanned readmission rate (Virtual PICU Systems, LLC) *paired with 0334
• 0343: PICU Standardized Mortality Ratio (Virtual PICU Systems, LLC)
Imaging
• 0513: Thorax CT: Use of contrast material (CMS)
More Articles on NQF:
NQF Endorses Additional Surgical Measures
NQF Endorses Measurement Framework for Multiple Chronic Conditions
NQF Endorses 19 Preventive Care, Screening Measures